Provectus Biopharmaceuticals (PVCT) News Today $0.11 -0.01 (-8.70%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 17, 2024 | americanbankingnews.comProvectus Biopharmaceuticals (OTCMKTS:PVCT) versus Korro Bio (NASDAQ:KRRO) Critical SurveyMay 21, 2024 | finance.yahoo.comProvectus Biopharmaceuticals Announces Poster Presentation of Rose Bengal Sodium for Treatment of Full-Thickness Cutaneous Wounds at SID 2024 Annual MeetingMay 14, 2024 | finance.yahoo.comProvectus Biopharmaceuticals Announces Eight Presentations of Rose Bengal Photodynamic Antimicrobial Therapy at ARVO 2024 Annual MeetingApril 18, 2024 | finance.yahoo.comProvectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose Bengal for Solid Tumor CancersApril 16, 2024 | finance.yahoo.comProvectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value CreationMarch 27, 2024 | finance.yahoo.comProvectus Biopharmaceuticals Announces Exclusive Worldwide License Agreement with University of Miami for Photodynamic Antimicrobial Treatment of Different Eye Infections with Rose Bengal SodiumMarch 12, 2024 | globenewswire.comProvectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and VaccinesMarch 7, 2024 | globenewswire.comProvectus Biopharmaceuticals Announces Acceptance of Cancer Immunotherapy PV-10 Abstract for HNSCC at AACR 2024 Annual MeetingFebruary 29, 2024 | globenewswire.comProvectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at 2024 Society for Investigative Dermatology (SID) Annual MeetingFebruary 23, 2024 | finance.yahoo.comProvectus Biopharmaceuticals, Inc. (PNK:PVCT) Q1 2024 Earnings Call TranscriptFebruary 15, 2024 | finance.yahoo.comProvectus Biopharmaceuticals Announces First Quarter 2024 Conference CallFebruary 15, 2024 | globenewswire.comProvectus Biopharmaceuticals Announces First Quarter 2024 Conference CallFebruary 14, 2024 | finance.yahoo.comProvectus Biopharmaceuticals Engages irlabs for Investor Relations ServicesFebruary 14, 2024 | globenewswire.comProvectus Biopharmaceuticals Engages irlabs for Investor Relations ServicesDecember 18, 2023 | finance.yahoo.comProvectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodium for Use as Anticancer and Antiviral Vaccine AdjuvantNovember 19, 2023 | morningstar.comProvectus Biopharmaceuticals Inc PVCTNovember 15, 2023 | finanznachrichten.deProvectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Advanced Cutaneous MelanomaNovember 15, 2023 | finance.yahoo.comProvectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Advanced Cutaneous MelanomaNovember 13, 2023 | finanznachrichten.deProvectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uveal MelanomaNovember 13, 2023 | finance.yahoo.comProvectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uveal MelanomaNovember 6, 2023 | finance.yahoo.comProvectus Biopharmaceuticals Announces Presentation of Preclinical PV-10 Vaccine Adjuvant Data at Society for Immunotherapy of Cancer (SITC) 2023 Annual MeetingNovember 2, 2023 | benzinga.comProvectus Algae Enters Into Livestock Methane Reduction Space Commissioning First Demonstration Biomanufacturing PlantAugust 7, 2023 | finance.yahoo.comProvectus Biopharmaceuticals Announces Acceptance of PV-10 Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023 Annual MeetingAugust 1, 2023 | finance.yahoo.comProvectus Biopharmaceuticals Announces Acceptance of PV-10 Poster Presentations at Society for Melanoma Research (SMR) 2023 CongressJune 28, 2023 | finance.yahoo.comProvectus Biopharmaceuticals Establishes Research Collaboration with University of Tennessee College of Veterinary Medicine to Investigate Pharmaceutical-Grade Small Molecule Immunotherapy Rose Bengal Sodium for Canine Soft Tissue SarcomasJune 3, 2023 | finance.yahoo.comPVCT - Provectus Biopharmaceuticals, Inc.May 12, 2023 | chron.comProvectus: Q1 Earnings SnapshotApril 20, 2023 | finance.yahoo.comProvectus Biopharmaceuticals Announces Publication of Activity of Pharmaceutical-Grade Rose Bengal Sodium (RBS) Against Colistin-Resistant Gram-Negative BacteriaApril 18, 2023 | technews.tmcnet.comHucu.ai and Provectus expand their relationship into a multi-year partnershipMarch 29, 2023 | marketwatch.comLyophilization Services for Biopharmaceuticals Market Growing Demand and Trends 2023 to 2031March 27, 2023 | marketwatch.comBiopharmaceutical Third Party Logistics (3PL) Market Growth and Competitive Landscape 2023-2029March 21, 2023 | venturebeat.comFormer Estée Lauder Executive Joins Provectus Algae as Cosmetics Advisor Signalling Industry ExpansionMarch 17, 2023 | forbes.comFive Areas Where AI Is Revolutionizing The Biopharmaceutical IndustryMarch 1, 2023 | venturebeat.comProvectus Algae Receives Strategic Investment from Biotech Leader CJ BioFebruary 26, 2023 | nasdaq.comRelative Strength Alert For Day One BiopharmaceuticalsFebruary 19, 2023 | marketwatch.comBiopharmaceutical Third Party Logistics (3PL) Market Size 2023 Will Touch A New Level In The Upcoming Year 2026January 24, 2023 | benzinga.comShort Volatility Alert: Provectus BiopharmJanuary 9, 2023 | finance.yahoo.comProvectus Biopharmaceuticals Releases 2023 Stockholder LetterDecember 31, 2022 | thestreet.comNYSE Places Provectus Listing Status Under ReviewDecember 12, 2022 | finance.yahoo.comProvectus Biopharmaceuticals Announces Decision to Not Undertake Reverse Split of Outstanding and Authorized Equities in 2022; Expects to Seek Same Stockholder Approval Again in 2023December 1, 2022 | finance.yahoo.comProvectus Biopharmaceuticals Announces New Data from Combination Therapy Trial of Small Molecule Cancer Immunotherapy PV-10® and Keytruda® for First-Line Stage III Melanoma at Melanoma Bridge 2022November 10, 2022 | finance.yahoo.comProvectus Biopharmaceuticals Announces Acceptance of Small Molecule Cancer Immunotherapy PV-10® Stage III Melanoma Abstract at Melanoma Bridge 2022November 2, 2022 | finance.yahoo.comProvectus Biopharmaceuticals Announces World Health Organization Selection of “Rose Bengal Sodium” as International Nonproprietary Name for Active Pharmaceutical IngredientOctober 26, 2022 | nz.finance.yahoo.comProvectus Algae Strengthens R&D Team, Reinforcing Commitment to Delivering Sustainable Synbio SolutionsOctober 25, 2022 | finance.yahoo.comProvectus Biopharmaceuticals Expands Research Collaboration with The Rockefeller University to Investigate Clinical-Stage Immuno-Dermatology Agent PH-10 for Skin InflammationOctober 20, 2022 | finance.yahoo.comProvectus Biopharmaceuticals, Inc. (PVCT)September 29, 2022 | finance.yahoo.comProvectus Biopharmaceuticals Establishes Research Collaboration with University of Texas Medical Branch at Galveston to Investigate Pharmaceutical-Grade Small Molecule Immunotherapy Rose Bengal for Wound HealingSeptember 21, 2022 | finance.yahoo.comProvectus Biopharmaceuticals Announces Exclusive License Option Agreement with Ophthalmic Biophysics Center of Bascom Palmer Eye Institute at University of Miami for Treatment of Eye InfectionsAugust 24, 2022 | finance.yahoo.comProvectus Biopharmaceuticals Expands Sponsored Research Collaboration with University of Tennessee Health Science Center to Investigate Pharmaceutical-Grade Rose Bengal as Anti-Fungal and Anti-Oral Bacterial AgentAugust 17, 2022 | finance.yahoo.comProvectus Biopharmaceuticals Expands Sponsored Research Collaboration with University of Calgary (Canada) to Investigate Systemic Administration of Pharmaceutical-Grade Rose Bengal for Treatment of Pediatric Leukemia Get Provectus Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PVCT and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here PVCT Media Mentions By Week PVCT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PVCT News Sentiment▼-1.000.61▲Average Medical News Sentiment PVCT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PVCT Articles This Week▼10▲PVCT Articles Average Week Get Provectus Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PVCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CHRS News OGI News PBYI News MCRB News LFCR News SKYE News RPTX News KOD News ADVM News GALT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PVCT) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provectus Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Provectus Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
